Sorry, you need to enable JavaScript to visit this website.
  1. Home
  3. Science
  4. Clinical Trials
  5. Plain Language Study Results Summaries
  6. Study Learn About

A Study to Learn About Nirmatrelvir/Ritonavir in Healthy Lactating Women

A Phase I, Multiple Dose, Open-Label Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women

Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: PAXLOVID
ClinicalTrials.gov Identifier (NCT): NCT05441215
Protocol ID: C4671039
DownloadPrint

Open Plain Language Summary Result:

Click here